Percutaneous transhepatic cholangiography

Last updated
Percutaneous transhepatic cholangiography
Perkutan transhepatische Cholangiographie.jpg
Percutaneous transhepatic cholangiography
Other namesPercutaneous hepatic cholangiogram
ICD-9-CM 87.51
OPS-301 code 3-13c.1

Percutaneous transhepatic cholangiography, percutaneous hepatic cholangiogram (PTHC) is a radiological technique used to visualize the anatomy of the biliary tract. [1] A contrast medium is injected into a bile duct in the liver, after which X-rays are taken. It allows access to the biliary tree in cases where endoscopic retrograde cholangiopancreatography has been unsuccessful. Initially reported in 1937, the procedure became popular in 1952. [2] [3]

Contents

Uses

Some uses for this procedure includes: drainage of bile/infected bile to relieve obstructive jaundice, to place a stent to dilate a stricture in the biliary system, stone removal, and rendezvous technique [4] where guidewire from the common bile duct (CBD) meets with duodenoscope (coming from the oesophagus into the stomach and then duodenum) at the major duodenal papilla. In this rendezvous technique, the guidewire is then pulled into duodenoscope and a small blade is slid over the guidewire into the CBD and perform surgeries on a specific bile duct in the biliary system. [5] PTHC is frequently performed guide therapy of the biliary system. Rarely it is used for diagnostic purposes only. [4]

PTHC is also used in the drainage of unruptured or uncomplicated hydatid cysts. Rarely, PTHC is used in the drainage of ruptured hydatid cysts. [6]

Contraindications

Among the contraindications are: increased bleeding tendency where platelets less than 100x109/litre and prothrombin time prolonged more than 2 seconds than the control. This procedure is also contraindicated in biliary tract sepsis, except to control the infection by drainage of the infected bile. [4]

Technique

Low osmolar contrast medium is used in this procedure with concentration of 150 mg/ml with 20 to 60 ml volume. Those who undergoes the procedure needs to be fasted for four hours before the procedure. Besides, antibiotics such as ciprofloxacin 500 mg to 750 mg can be given as antibiotic prophylaxis to prevent infection during the procedure. Sedation (to reduce irritability and agitation of the subject during procedure) with analgesia (painkillers) and vital signs monitoring should be set up. Before the procedure, bedside ultrasound is done to confirm the position of the dilated bile ducts in the liver. The puncture site is then marked. Bile ducts of the right liver is located in the intercostal spaces between anterior and mid axillary lines. Meanwhile, the bile ducts in the left lobe of the liver is located to the left side of the xiphisternum on the epigastric region. [4]

The number of attempts made to pass Chiba needle into the biliary tract does not affect the rate of complication but the likehood of success is related to the degree of dilatation of the biliary tract (larger dilatation means needle is easier to find its way into the biliary tract) and total number of attempts made. [4]

Excessive contrast media injection into the liver should be avoided. When there is excessive injection into the liver, lymphatics within the liver will be opacified with contrast medium. Injection of the contrast medium into an artery or vein will cause the contrast to dispersed quickly due to blood flow. [4]

Cholangiography during a biliary drainage intervention is called perioperative or primary choloangiography, and when performed later in the same drain it is called secondary cholangiography. [7]

Complications

Percutaneous transhepatic cholangiography may increase the incidence of metastasis, tube dislocation, and bleeding when compared to endoscopic biliary drainage. However, it has lower rate of cholangitis, pancreatitis when compared to endoscopic biliary drainage, probably because the latter has higher chance of incomplete drainage of infected bile, or accidental resection of papilla that causes the backflow of infected bile from the duodenum into the biliary system. [8] [9]

Percutaneous transhepatic biliary drainage

Percutaneous transhepatic biliary drainage (PTBD) is often performed if endoscopic retrograde biliary drainage (ERBD) is unsuccessful for biliary obstructions due to hepatocellular carcinoma. ERBD is the first line treatment because of its low bleeding risk. For biliary obstruction at the hilum (meeting point of right and hepatic hepatic ducts), both ERBD and PTBD can be done depending on subject's clinical circumstances and physician's preference. [10]

Percutaneous extraction of retained biliary calculi

Percutaneous transhepatic technique

This procedure is indicated when endoscopic retrograde cholangiopancreatography (ERCP), papillotomy (cutting through major duodenal papilla to relieve stenosis) or stone removal are unsuccessful. This procedure is also indicated when endoscopic access is difficult in case where there is major modification of the stomach and small intestine such as Billroth II stomach resection, and other conditions such as intradiverticular papilla (duodenal papilla located inside a duodenal outpouching), stenosis of the duodenal papilla, stone within the distal CBD, stenosis of ampulla of Vater, stone in the peripheral bile duct, or stone larger than 15 mm. [11]

Biliary calculi is seen on cholangiogram done on T-tube that was previously inserted into CBD. This happens in 3% of the cases post surgical management of biliary stones. This procedure is contraindicated if T-tube is too small (less than 12 French in size), tortous T tube in tissues, acute pancreatitis, and when there is another drain that is connected to the T-tube tract. [4]

PTBD is done one to two weeks before the procedure to reduce oedema of the biliary ducts and sphincter of Oddi oedema. [12]

Either high osmolar contrast medium or low osmolar contrast medium can be used (with concentration of 150 mg/ml). Low density contrast medium is used to prevent obscuring of the calculus. Antibiotic prophylaxis and pre-medication is given one hour before the procedure. Painkillers is given during the procedure. The subject lie down in supine position on the table. PTHC is performed if biliary drainage catheter is not in-situ. The drainage catheter is then removed over the guidewire and sheath is inserted into the ducts (7 to 8 French size). Contrast is then injected through the sheath to identify any stones or strictures. If a stricture is identified, put in biliary manipulation catheter with guidewire measuring 0.035 inches and commence balloon dilatation (with balloon sizes of 8, 10, and 12 mm). Using the balloon catheter, the stones are pushed into the duodenum. If the stones are difficult to push, Dormier basket is used to push them into the duodenum. The basket is removed and guidewire is inserted back into the sheath. The sheath is then removed and biliary drainage catheter is inserted back through the guidewire. Contrast is then injected intermittently through the drainage catheter to follow-up on the position of the stones. [4]

After the procedure, pulse and blood pressure are monitored half-hourly for six hours. The subject put on bed rest for a total of four to six hours. [4]

Possible complications include allergic reaction to the contrast and inflammation of the pancreas. There can also be perforation of the T-tube tract. [4]

Trans T-tube technique

Post-operative T-tube cholangiography is performed on the 10th day post operation where either high osmolar or low osmolar contrast media with concentration of 150 mg/ml with volume of 20 to 30 ml is injected through the T-tube to determine if there is any leak from the biliary tract or remaining stones within the biliary system. [4]

Trans T-tube technique of stone extraction also known as Burhene technique. This procedure is done after 5 to 8 weeks post abdominal operation for the maturation of the T-tube tract when fibrous tissue is formed at its walls to support the tract and keep the tract open. [11] Guidewire is then advanced through the T-tube before the T-tube is removed. Then a catheter is inserted over the guidewire and cholangiogram is performed to visualise the anatomy of the biliary tract and the positions of the stones. [11]

Related Research Articles

<span class="mw-page-title-main">Gallbladder</span> Organ in humans and other vertebrates

In vertebrates, the gallbladder, also known as the cholecyst, is a small hollow organ where bile is stored and concentrated before it is released into the small intestine. In humans, the pear-shaped gallbladder lies beneath the liver, although the structure and position of the gallbladder can vary significantly among animal species. It receives and stores bile, produced by the liver, via the common hepatic duct, and releases it via the common bile duct into the duodenum, where the bile helps in the digestion of fats.

<span class="mw-page-title-main">Bile duct</span> Type of organ

A bile duct is any of a number of long tube-like structures that carry bile, and is present in most vertebrates.

<span class="mw-page-title-main">Caroli disease</span> Medical condition

Caroli disease is a rare inherited disorder characterized by cystic dilatation of the bile ducts within the liver. There are two patterns of Caroli disease: focal or simple Caroli disease consists of abnormally widened bile ducts affecting an isolated portion of liver. The second form is more diffuse, and when associated with portal hypertension and congenital hepatic fibrosis, is often referred to as "Caroli syndrome". The underlying differences between the two types are not well understood. Caroli disease is also associated with liver failure and polycystic kidney disease. The disease affects about one in 1,000,000 people, with more reported cases of Caroli syndrome than of Caroli disease.

<span class="mw-page-title-main">Stent</span> Type of medical device

In medicine, a stent is a tube usually constructed of a metallic alloy or a polymer. It is inserted into the lumen of an anatomic vessel or duct to keep the passageway open. Stenting refers to the placement of a stent. The word "stent" is also used as a verb to describe the placement of such a device, particularly when a disease such as atherosclerosis has pathologically narrowed a structure such as an artery.

<span class="mw-page-title-main">Cholecystectomy</span> Surgical removal of the gallbladder

Cholecystectomy is the surgical removal of the gallbladder. Cholecystectomy is a common treatment of symptomatic gallstones and other gallbladder conditions. In 2011, cholecystectomy was the eighth most common operating room procedure performed in hospitals in the United States. Cholecystectomy can be performed either laparoscopically, or via an open surgical technique.

<span class="mw-page-title-main">Endoscopic retrograde cholangiopancreatography</span> Use of endoscopy and fluoroscopy to treat and diagnose digestive issues.

Endoscopic retrograde cholangiopancreatography (ERCP) is a technique that combines the use of endoscopy and fluoroscopy to diagnose and treat certain problems of the biliary or pancreatic ductal systems. It is primarily performed by highly skilled and specialty trained gastroenterologists. Through the endoscope, the physician can see the inside of the stomach and duodenum, and inject a contrast medium into the ducts in the biliary tree and pancreas so they can be seen on radiographs.

<span class="mw-page-title-main">Common bile duct</span> Gastrointestinal duct

The bile duct is a part of the biliary tract. It is formed by the union of the common hepatic duct and cystic duct. It ends by uniting with the pancreatic duct to form the hepatopancreatic ampulla. It possesses its own sphincter to enable regulation of bile flow.

<span class="mw-page-title-main">Cholangiography</span>

Cholangiography is the imaging of the bile duct by x-rays and an injection of contrast medium.

<span class="mw-page-title-main">Common bile duct stone</span> Medical condition

Common bile duct stone, also known as choledocholithiasis, is the presence of gallstones in the common bile duct (CBD). This condition can cause jaundice and liver cell damage. Treatments include choledocholithotomy and endoscopic retrograde cholangiopancreatography (ERCP).

<span class="mw-page-title-main">Common hepatic duct</span> Exocrine duct

The common hepatic duct is the first part of the biliary tract. It joins the cystic duct coming from the gallbladder to form the common bile duct.

<span class="mw-page-title-main">Cholestasis</span> Medical condition

Cholestasis is a condition where the flow of bile from the liver to the duodenum is impaired. The two basic distinctions are:

<span class="mw-page-title-main">Nephrostomy</span> Surgical procedure that creates a long-term opening between the kidney and the skin

A nephrostomy or percutaneous nephrostomy is an artificial opening created between the kidney and the skin which allows for the urinary diversion directly from the upper part of the urinary system. It is an interventional radiology/surgical procedure in which the renal pelvis is punctured whilst using imaging as guidance. Images are obtained once an antegrade pyelogram, with a fine needle, has been performed. A nephrostomy tube may then be placed to allow drainage.

<span class="mw-page-title-main">Biliary fistula</span> Medical condition

A biliary fistula is a type of fistula in which bile flows along an abnormal connection from the bile ducts into a nearby hollow structure. Types of biliary fistula include:

<span class="mw-page-title-main">Ascending cholangitis</span> Medical condition

Ascending cholangitis, also known as acute cholangitis or simply cholangitis, is inflammation of the bile duct, usually caused by bacteria ascending from its junction with the duodenum. It tends to occur if the bile duct is already partially obstructed by gallstones.

<span class="mw-page-title-main">Self-expandable metallic stent</span>

A self-expandable metallic stent is a metallic tube, or stent that holds open a structure in the gastrointestinal tract to allow the passage of food, chyme, stool, or other secretions related to digestion. Surgeons insert SEMS by endoscopy, inserting a fibre optic camera—either through the mouth or colon—to reach an area of narrowing. As such, it is termed an endoprosthesis. SEMS can also be inserted using fluoroscopy where the surgeon uses an X-ray image to guide insertion, or as an adjunct to endoscopy.

Cholecystostomy or (cholecystotomy) is a medical procedure used to drain the gallbladder through either a percutaneous or endoscopic approach. The procedure involves creating a stoma in the gallbladder, which can facilitate placement of a tube or stent for drainage, first performed by American surgeon, Dr. John Stough Bobbs, in 1867. It is sometimes used in cases of cholecystitis or other gallbladder disease where the person is ill, and there is a need to delay or defer cholecystectomy. The first endoscopic cholecystostomy was performed by Drs. Todd Baron and Mark Topazian in 2007 using ultrasound guidance to puncture the stomach wall and place a plastic biliary catheter for gallbladder drainage.

Intravenous cholangiography is a form of cholangiography that was introduced in 1954.

<span class="mw-page-title-main">Biloma</span> Circumscribed abdominal collection of bile outside the biliary tree

A biloma is a circumscribed abdominal collection of bile outside the biliary tree. It occurs when there is excess bile in the abdominal cavity. It can occur during or after a bile leak. There is an increased chance of a person developing biloma after having a gallbladder removal surgery, known as laparoscopic cholecystectomy. This procedure can be complicated by biloma with incidence of 0.3–2%. Other causes are liver biopsy, abdominal trauma, and, rarely, spontaneous perforation. The formation of biloma does not occur frequently. Biliary fistulas are also caused by injury to the bile duct and can result in the formation of bile leaks. Biliary fistulas are abnormal communications between organs and the biliary tract. Once diagnosed, they usually require drainage. The term "biloma" was first coined in 1979 by Gould and Patel. They discovered it in a case with extrahepatic bile leakage. The cause of this was trauma to the upper right quadrant of the abdomen. Originally, biloma was described as an "encapsulated collection" of extrahepatic bile. Biloma is now described as extrabiliary collections of bile that can be either intrahepatic or extrahepatic. The most common cause of biloma is trauma to the liver. There are other causes such as abdominal surgery, endoscopic surgery and percutaneous catheter drainage. Injury and abdominal trauma can cause damage to the biliary tree. The biliary tree is a system of vessels that direct secreations from the liver, gallbladder, and pancreas through a series of ducts into the duodenum. This can result in a bile leak which is a common cause of the formation of biloma. It is possible for biloma to be associated with mortality, though it is not common. Bile leaks occur in about one percent of causes.

<span class="mw-page-title-main">Choledochoduodenostomy</span>

Choledochoduodenostomy (CDD) is a surgical procedure to create an anastomosis, a surgical connection, between the common bile duct (CBD) and an alternative portion of the duodenum. In healthy individuals, the CBD meets the pancreatic duct at the ampulla of Vater, which drains via the major duodenal papilla to the second part of duodenum. In cases of benign conditions such as narrowing of the distal CBD or recurrent CBD stones, performing a CDD provides the diseased patient with CBD drainage and decompression. A side-to-side anastomosis is usually performed.

<span class="mw-page-title-main">Biliary endoscopic sphincterotomy</span> Use of endoscopy and fluoroscopy to treat and diagnose digestive issues.

Biliary endoscopic sphincterotomy is a procedure where the sphincter of Oddi and the segment of the common bile duct where it enters the duodenum are cannulated and then cut with a sphincterotome, a device that includes a wire which cuts with an electric current (electrocautery).

References

  1. Young, Michael; Mehta, Dhruv (2023), "Percutaneous Transhepatic Cholangiogram", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   29630242 , retrieved 2023-11-24
  2. Carter RF, Saypol GM (1952). "Transabdominal cholangiography". Journal of the American Medical Association. 148 (4): 253–5. doi:10.1001/jama.1952.02930040009002. PMID   14888454.
  3. Atkinson M, Happey MG, Smiddy FG (1960). "Percutaneous transhepatic cholangiography". Gut. 1 (4): 357–65. doi:10.1136/gut.1.4.357. PMC   1413224 . PMID   13684978.
  4. 1 2 3 4 5 6 7 8 9 10 11 Watson N, Jones H (2018). Chapman and Nakielny's Guide to Radiological Procedures. Elsevier. pp. 111–112, 112–113, 117–118. ISBN   9780702071669.
  5. Ayala, Juan C.; Labbe, Ricardo; Vera, Juan E. (April 2008). "SHORT (SHOrt Rendezvous Technique): A New ERCP Rendezvous Technique". Gastrointestinal Endoscopy. 67 (5): AB159–AB160. doi:10.1016/j.gie.2008.03.351.
  6. Inal, Mehmet; Soyupak, Süreyya; Akgül, Erol; Ezici, Hüseyin (2002-10-01). "Percutaneous Transhepatic Endobiliary Drainage of Hepatic Hydatid Cyst with Rupture into the Biliary System: An Unusual Route for Drainage". CardioVascular and Interventional Radiology. 25 (5): 437–439. doi:10.1007/s00270-001-0091-x. ISSN   0174-1551.
  7. Schuberth, O. O.; Sjogren, S. E. (2010). "On Cholangiography". Acta Radiologica. 22 (5–6): 780–795. doi:10.3109/00016924109136457. ISSN   0001-6926.
  8. Duan, Feng; Cui, Li; Bai, Yanhua; Li, Xiaohui; Yan, Jieyu; Liu, Xuan (December 2017). "Comparison of efficacy and complications of endoscopic and percutaneous biliary drainage in malignant obstructive jaundice: a systematic review and meta-analysis". Cancer Imaging. 17 (1): 27. doi: 10.1186/s40644-017-0129-1 . ISSN   1470-7330. PMC   5644169 . PMID   29037223.
  9. Wang, Lei; Lin, Nanping; Xin, Fuli; Ke, Qiao; Zeng, Yongyi; Liu, Jingfeng (December 2019). "A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction". World Journal of Surgical Oncology. 17 (1): 116. doi: 10.1186/s12957-019-1656-y . ISSN   1477-7819. PMC   6612106 . PMID   31277666.
  10. Kolev, Nikola Y.; Ignatov, Valentin L.; Tonev, Anton Y. (2013-11-20). "Biliary Drainage". Journal of IMAB - Annual Proceeding (Scientific Papers). 19 (3): 465–469. doi: 10.5272/jimab.2013193.465 .
  11. 1 2 3 Ilgit, Erhan T; Gürel, Kamil; Önal, Baran (September 2002). "Percutaneous management of bile duct stones". European Journal of Radiology. 43 (3): 237–245. doi:10.1016/S0720-048X(02)00159-6.
  12. Cheng, Jhm; Leung, Wkw; Wong, Ahc; Lee, Bkh; Leung, Bst; Chu, Cy; Kan, Wk (2020-06-19). "Percutaneous Transhepatic Biliary Stones Removal — An Effective and Safe Alternative". Hong Kong Journal of Radiology. 23 (2): 106–113. doi: 10.12809/hkjr2016940 .